RecruitingNCT05883540
LSD or active placebo for psychosocial distress in palliative care: a Phase II study
About this title
Read the official source — NCT05883540Medication studyAges 22+SwitzerlandAnxiety
Understand this study
Who could participate?
Listed age limits: from 22 years.
- Listed locations
- Basel and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 9, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Switzerland
- Age range
- Over 22 Years
- Official registry ID
- NCT05883540
- Official title
Show the full official title
Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Basel · Collonge-Bellerive · Uster
1 more locations
- Zurich
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Basel, Switzerland, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Lysergic Acid Diethylamide Tartrate.
Who can participate?
Listed age limits: from 22 years.
Is this study still recruiting?
The registry lists this study as recruiting.
